Fjarde Ap-fonden’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-68,005
| Closed | -$12.5M | – | 567 |
|
2021
Q2 | $12.5M | Sell |
68,005
-3,100
| -4% | -$569K | 0.11% | 177 |
|
2021
Q1 | $10.9M | Buy |
71,105
+1,300
| +2% | +$199K | 0.1% | 207 |
|
2020
Q4 | $10.9M | Sell |
69,805
-7,000
| -9% | -$1.09M | 0.1% | 188 |
|
2020
Q3 | $8.79M | Buy |
76,805
+8,300
| +12% | +$950K | 0.1% | 199 |
|
2020
Q2 | $7.69M | Buy |
68,505
+4,600
| +7% | +$516K | 0.1% | 213 |
|
2020
Q1 | $5.74M | Sell |
63,905
-1,100
| -2% | -$98.8K | 0.09% | 212 |
|
2019
Q4 | $7.03M | Buy |
65,005
+4,800
| +8% | +$519K | 0.09% | 242 |
|
2019
Q3 | $5.9M | Buy |
60,205
+4,309
| +8% | +$422K | 0.08% | 275 |
|
2019
Q2 | $7.32M | Sell |
55,896
-7,100
| -11% | -$930K | 0.09% | 241 |
|
2019
Q1 | $8.52M | Buy |
62,996
+12,064
| +24% | +$1.63M | 0.11% | 204 |
|
2018
Q4 | $4.96M | Sell |
50,932
-8,100
| -14% | -$789K | 0.09% | 242 |
|
2018
Q3 | $8.21M | Sell |
59,032
-2,600
| -4% | -$361K | 0.12% | 185 |
|
2018
Q2 | $7.65M | Buy |
61,632
+349
| +0.6% | +$43.3K | 0.12% | 192 |
|
2018
Q1 | $6.83M | Sell |
61,283
-104
| -0.2% | -$11.6K | 0.1% | 214 |
|
2017
Q4 | $7.34M | Buy |
61,387
+8,916
| +17% | +$1.07M | 0.11% | 200 |
|
2017
Q3 | $7.36M | Buy |
52,471
+1,039
| +2% | +$146K | 0.14% | 169 |
|
2017
Q2 | $6.26M | Buy |
51,432
+6,879
| +15% | +$837K | 0.13% | 181 |
|
2017
Q1 | $5.4M | Sell |
44,553
-3,460
| -7% | -$420K | 0.13% | 180 |
|
2016
Q4 | $5.87M | Sell |
48,013
-4,642
| -9% | -$568K | 0.14% | 168 |
|
2016
Q3 | $6.45M | Buy |
52,655
+1,083
| +2% | +$133K | 0.14% | 161 |
|
2016
Q2 | $6.02M | Buy |
51,572
+206
| +0.4% | +$24.1K | 0.14% | 167 |
|
2016
Q1 | $7.15M | Buy |
51,366
+6,369
| +14% | +$887K | 0.17% | 139 |
|
2015
Q4 | $8.58M | Buy |
44,997
+610
| +1% | +$116K | 0.23% | 99 |
|
2015
Q3 | $6.94M | Sell |
44,387
-2,861
| -6% | -$447K | 0.19% | 118 |
|
2015
Q2 | $8.54M | Buy |
47,248
+2,532
| +6% | +$458K | 0.21% | 112 |
|
2015
Q1 | $7.75M | Sell |
44,716
-2,237
| -5% | -$388K | 0.18% | 131 |
|
2014
Q4 | $8.69M | Sell |
46,953
-3,262
| -6% | -$604K | 0.19% | 119 |
|
2014
Q3 | $8.33M | Sell |
50,215
-4,120
| -8% | -$683K | 0.18% | 128 |
|
2014
Q2 | $8.49M | Sell |
54,335
-1,992
| -4% | -$311K | 0.17% | 138 |
|
2014
Q1 | $8.57M | Buy |
56,327
+2,012
| +4% | +$306K | 0.17% | 137 |
|
2013
Q4 | $7.23M | Sell |
54,315
-3,476
| -6% | -$463K | 0.15% | 150 |
|
2013
Q3 | $6.71M | Sell |
57,791
-4,288
| -7% | -$498K | 0.14% | 161 |
|
2013
Q2 | $5.73M | Buy |
+62,079
| New | +$5.73M | 0.12% | 196 |
|